bullish
Zai Lab IPO: Experienced Team, Promising In-Licensing Drug Pipeline (Part 1)
1.5k Views13 Sep 2017 14:32
Zai Lab is looking to raise US$100m in the US listing. The company has a short history of three years and does not have a commercial product at the...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
x